CIB2 and ovarian cancer: Our previous work demonstrated that mislocalised SPHK1, caused by loss of a negative regulator protein, calcium and integrin binding protein 2 (CIB2), promoted tumour growth, metastasis and chemotherapeutic resistance in ovarian cancer cell lines and a xenograft mouse model [25].